Danny Wiederkehr

Danny Wiederkehr

Company: Pfizer

Job title: Senior Director, Global HEOR Team Lead


Danny Wiederkehr is the Global Lead for the Health Economics and Outcomes Research (HEOR) Team supporting cardiovascular medicine at Pfizer. Danny believes we have only slightly tapped the potential of real world evidence to drive better decision making in healthcare, improve the efficiency of care delivery and improve patient outcomes. With Pfizer for 9 years, he has held several roles across Medical Affairs, Global Policy, and Real World Data and Analytics, developing a deep appreciation for the intersection of clinical expertise, policy knowledge, analytic tools that is driving innovation in real world evidence generation. Prior to joining Pfizer, Danny led several life science consulting teams and has published over 80 analyses using healthcare claims databases, electronic health records, and national health surveys. He holds an undergraduate degree in Mathematics and Gender Studies from the University of Notre Dame and a Masters of Public Health in Health Policy and Management from Columbia University.


Evolving Real World Evidence Strategy Across Lifecycle – Improving Evidence for Patient Care 2:45 pm

• Identifying gaps is easy, addressing them requires a deep understanding of data sources available, including strengths, limitations, and accessibility • Generating relevant RWE requires understanding of key audience needs, their understanding of RWE, and credible methods and data sources • Successful RWE programs reflect cross-functional expertise and collaboration across internal and external stakeholders with…Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.